A Discounted Cash Flow, or DCF, model estimates what a company might be worth today by projecting its future cash flows and discounting them back to a present value.
For Science Applications International, the model uses a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about $578 million. Analyst and extrapolated projections suggest annual free cash flow figures in the $580 million to about $586 million range over the coming decade, with a specific estimate of $561 million in 2029. Simply Wall St discounts these future cash flows to today using its own assumptions.
On this basis, the DCF model estimates an intrinsic value of about $200.23 per share. Compared with the current share price of US$95.71, this implies the stock is about 52.2% undervalued according to these inputs and assumptions.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Science Applications International is undervalued by 52.2%. Track this in your watchlist or portfolio, or discover 61 more high quality undervalued stocks.
For a profitable company, the P/E ratio is a simple way to see how much you are paying for each dollar of earnings. This makes it a useful cross check against a DCF model. Higher growth expectations or lower perceived risk tend to justify a higher “normal” P/E, while slower growth or higher risk usually align with a lower multiple.
Science Applications International currently trades on a P/E of 11.61x. This sits below the Professional Services industry average P/E of 19.69x and also below the peer group average of 32.81x. Simply Wall St’s Fair Ratio for the stock is 15.33x, which reflects the P/E that might be considered appropriate given factors such as its earnings profile, industry, profit margins, size and risk characteristics.
The Fair Ratio is generally more tailored than a simple comparison with peers or the broad industry because it tries to account for company specific features rather than assuming all firms should trade on the same headline multiple. Comparing Science Applications International’s current P/E of 11.61x with the Fair Ratio of 15.33x suggests the shares trade at a discount on this metric.
Result: UNDERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.
Earlier it was mentioned that there is an even better way to understand valuation. Here is an introduction to Narratives, which let you attach a clear story about Science Applications International to the numbers you see, by linking your view of future revenue, earnings and margins to a fair value that can be compared with today’s share price.
A Narrative on Simply Wall St’s Community page is an accessible tool that helps you spell out why you think the company looks attractive or risky, ties that story to a specific financial forecast, and then shows the implied fair value so you can judge whether the current price looks high or low relative to your expectations.
Because Narratives update automatically when new information such as earnings, guidance or contract news comes in, you can see in real time how a more optimistic view, such as a fair value of about US$130.00, and a more cautious view, such as a fair value of about US$86.80, reflect very different assumptions about Science Applications International and lead to different conclusions on whether the gap between price and fair value is wide enough for you to consider buying, holding or selling.
For Science Applications International, we will make it really easy for you with previews of two leading Science Applications International Narratives:
🐂 Science Applications International Bull Case
Fair value in this bullish narrative: US$130.00 per share
Implied discount to this fair value versus the last close of US$95.71: about 26.4% undervalued
Revenue growth assumption used: 1.52% per year
🐻 Science Applications International Bear Case
Fair value in this bearish narrative: about US$86.80 per share
Implied premium to this fair value versus the last close of US$95.71: about 10.3% overvalued
Revenue growth assumption used: 2.02% annual decline
Taken together, these Narratives show how different views on contract wins, federal IT spending and margin resilience can lead to very different fair values. Your next step is to decide which story feels closer to how you see Science Applications International today and adjust the numbers to match your own expectations.
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Science Applications International on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
Do you think there's more to the story for Science Applications International? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com